Optimal Vitamin D Supplementation Levels for Cardiovascular Disease Protection - Wikidata - wikimedia - TriplyDB

Optimal Vitamin D Supplementation Levels for Cardiovascular Disease Protection

Optimal Vitamin D Supplementation Levels for Cardiovascular Disease Protection

http://www.wikidata.org/entity/Q26782269

about

Vitamin D3 for the Treatment of Epilepsy: Basic Mechanisms, Animal Models, and Clinical Trials Maternal vitamin D depletion alters DNA methylation at imprinted loci in multiple generations.Older Swedish Adults with High Self-Perceived Health Show Optimal 25-Hydroxyvitamin D Levels Whereas Vitamin D Status Is Low in Patients with High Disease Burden Diet-induced vitamin D deficiency has no effect on acute post-stroke outcomes in young male mice.Hypovitaminosis D in patients with heart failure: effects on functional capacity and patients' survival.Vitamin D3 Supplementation Reduces Subsequent Brain Injury and Inflammation Associated with Ischemic Stroke.Serum 25-hydroxyvitamin D levels in patients with skin diseases including psoriasis, infections, and atopic dermatitis.Nontraditional Cardiovascular Biomarkers and Risk Factors: Rationale and Future Perspectives.

P2860

Q28069486-3E511BDE-F805-4910-ADDA-217B7C974722 Q37336786-EE033A15-F7F3-4CC2-A4CC-3B81806F94BA Q37463317-42B52D98-607D-492F-A849-7FF93C7F471C Q38612827-A0C78B7A-2876-4E74-BEE3-902903E49D9C Q48366666-FFB1127F-026F-46C3-B3DA-71639504FA64 Q52687545-E31FB8AC-EB6D-45AB-87EF-B18C5C4B696F Q55229606-FB6CE0AC-BF03-4666-8D08-C22C42A48E9B Q55384368-27D37B8C-7734-4D49-BC32-E4156C3C2D04

P2860

Optimal Vitamin D Supplementation Levels for Cardiovascular Disease Protection

http://www.wikidata.org/entity/Q26782269

description

2015 nî lūn-bûn

@nan

2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

name

Optimal Vitamin D Supplementation Levels for Cardiovascular Disease Protection

@ast

Optimal Vitamin D Supplementation Levels for Cardiovascular Disease Protection

@en

Optimal Vitamin D Supplementation Levels for Cardiovascular Disease Protection

@nl

type

label

Optimal Vitamin D Supplementation Levels for Cardiovascular Disease Protection

@ast

Optimal Vitamin D Supplementation Levels for Cardiovascular Disease Protection

@en

Optimal Vitamin D Supplementation Levels for Cardiovascular Disease Protection

@nl

prefLabel

Optimal Vitamin D Supplementation Levels for Cardiovascular Disease Protection

@ast

Optimal Vitamin D Supplementation Levels for Cardiovascular Disease Protection

@en

Optimal Vitamin D Supplementation Levels for Cardiovascular Disease Protection

@nl

P1433

Q26782269-165C51BF-ED93-41D0-9271-48A4E1A35F1A

P1476

Q26782269-E19F4DB3-3A77-4A58-B7C2-FA179C5F74FA

P2093

Q26782269-22CFEE7A-5A4A-420C-87F5-A6F16E53ADCA

Q26782269-F45630A0-CB96-4F8B-AF16-DA9573D0DD23

P275

Q26782269-A56F07A7-0197-428F-A482-4BB5F4061BED

P2860

Q26782269-019BC98B-D978-4089-AE4C-B6B6217DD7E4

Q26782269-02DCC397-5BAA-48C7-9AC7-D1A5640913BA

Q26782269-0395EA25-F23E-42E5-AA66-20A944738041

Q26782269-0B2B86DA-8001-4186-B06F-84A7F7C0DD6E

Q26782269-161C2EF4-BA42-4EA9-8CAF-D8A473C00C5F

Q26782269-1C307D69-35A1-482B-BCDC-BB77782EBEC6

Q26782269-208E0181-1828-4791-BB7C-F512DA23E409

Q26782269-269CCF9A-0E82-441D-9177-780EA027BAB4

Q26782269-2A13EDBB-F8B0-42D9-92B3-0B4C8D95B950

Q26782269-31576E70-C53C-4CD9-A1B0-920CB61E8391

P304

Q26782269-5FBD3D88-AE5B-46F1-8556-6953710872C2

P31

Q26782269-0B0459A4-C126-4A38-877B-9B887878D4AE

Q26782269-5A6D3653-4313-455E-AFFE-B6A5556459B8

P3181

Q26782269-4C1B8A38-6294-43B3-93F0-43B16895BA4F

P356

Q26782269-4F90ECC3-192F-47D8-AB49-A109A3200F06

P407

Q26782269-70E44864-05BE-4A5A-A81A-A7B91079F37C

P478

Q26782269-21EAB98A-BCF1-4AC2-869C-C579BC43B46D

P50

Q26782269-529553D2-8698-4158-9A7B-544339B44FE0

P5008

Q26782269-7527FA6C-2841-49DC-A0FF-BB10ACFEAD49

P577

Q26782269-D198950A-CB14-433C-B7D5-51E0CE2E3427

P5875

Q26782269-4815BEDD-CC5A-4C29-82D7-FFC082598FC1

P698

Q26782269-067E1B7F-3AE8-4D45-BA66-DC89954186C6

P921

Q26782269-831320B9-DDC8-42C4-A6DE-95C68BD07513

Q26782269-90BCE842-D535-42F7-95A9-D740B648BA93

Q26782269-93569DC9-4CB1-4FFF-8C2E-DB27E33B8D9C

Q26782269-AA8EE7B2-C4D4-4EA8-89BB-F2753BF97B61

Q26782269-D8A6BD9E-6701-4E6E-99D3-B5D07281C274

Q26782269-a5cc3317-1a9a-4dd8-891a-ea9f9fe53efe

P932

Q26782269-3D8CF174-B137-4743-AC43-ED8EEA45E090

P3181

P356

P1433

Disease Markers

P1476

Optimal Vitamin D Supplementation Levels for Cardiovascular Disease Protection

@en

P2093

Phillip A Howells

http://www.w3.org/2001/XMLSchema#string

Sebastian T Lugg

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline

The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know

Vitamin D supplementation for prevention of mortality in adults

25-hydroxyvitamin D3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds

25-hydroxyvitamin D levels and the risk of mortality in the general population

Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D

Vitamin D deficiency

Vitamin D toxicity, policy, and science

Role of vitamin D in atherosclerosis

P304

864370

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3016283

http://www.w3.org/2001/XMLSchema#string

P356

10.1155/2015/864370

http://www.w3.org/2001/XMLSchema#string

P407

P478

2015

http://www.w3.org/2001/XMLSchema#string

P50

David R Thickett

P5008

P577

2015-09-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281591264

http://www.w3.org/2001/XMLSchema#string

P698

26435569

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease

polycyclic compound

physiological phenomena

clinical chemistry

P932

4578836

http://www.w3.org/2001/XMLSchema#string